FDA Review Of Dental Amalgam - Advisory Panel To Consider Risks To Vulnerable Patients
Editor's ChoiceMain Category: Dentistry
Article Date: 12 Jun 2010 - 0:00 PDT
| Patient / Public: | ![]() |
5 (2 votes) |
| Healthcare Prof: | ![]() |
3 (2 votes) |
The US FDA (Food and Drug Administration) say it is to hold an advisory panel on December 14th-15th to discuss a number of scientific issues that may affect dental amalgam regulation, used for direct filling of carious lesions or structural faults in teeth. The meeting will focus mainly on the possible risk to vulnerable patients, such as pregnant women, young children and fetuses.
Amalgam is used for the treatment of tooth decay. It consists of a mixture of metals, composed of liquid mercury and powdered amalgam alloy, made up mainly of silver, tin and copper.
On July 28, 2009, the FDA issued a final rule that reclassified dental mercury from a class I device to class II, classified dental amalgam as a class II device, and designated special controls for dental amalgam, mercury and amalgam alloy. The special control for the devices is a guidance titled, "Class II Special Controls Guidance Document: Dental Amalgam, Mercury and Amalgam Alloy."
Since that final rule, the FDA has received numerous petitions raising various issues regarding the final rule and special controls.
Concerns raised include:
- The adequacy of the risk assessment method used by the FDA in classifying dental amalgam.
- The bioaccumulative effect of mercury, the exposure of pediatric populations to mercury vapor.
- The adequacy of the clinical studies on dental amalgam.
Source: FDA
Written by Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/articles/191580.php>
APA
http://www.medicalnewstoday.com/articles/191580.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




